{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "67877-890",
      "generic_name": "Mirabegron",
      "labeler_name": "Ascend Laboratories, LLC",
      "brand_name": "Mirabegron",
      "active_ingredients": [
        {
          "name": "MIRABEGRON",
          "strength": "8 mg/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "67877-890-88",
          "description": "1 POUCH in 1 CARTON (67877-890-88)  / 1 BOTTLE in 1 POUCH / 100 mL in 1 BOTTLE",
          "marketing_start_date": "20260615",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Ascend Laboratories, LLC"
        ],
        "rxcui": [
          "2541233"
        ],
        "spl_set_id": [
          "1c9022af-4841-4f3f-9737-1c5eef58e86b"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000185008",
          "N0000185007",
          "N0000182137",
          "N0000190114",
          "N0000185503"
        ],
        "pharm_class_epc": [
          "beta3-Adrenergic Agonist [EPC]"
        ],
        "pharm_class_moa": [
          "Adrenergic beta3-Agonists [MoA]",
          "Cytochrome P450 2D6 Inhibitors [MoA]",
          "Cytochrome P450 3A Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]"
        ],
        "unii": [
          "MVR3JL3B2V"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "FOR SUSPENSION, EXTENDED RELEASE",
      "spl_id": "bea3fc38-dab4-4a11-b7a1-911b302f6504",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20260615",
      "product_id": "67877-890_bea3fc38-dab4-4a11-b7a1-911b302f6504",
      "application_number": "ANDA219323",
      "brand_name_base": "Mirabegron",
      "pharm_class": [
        "Adrenergic beta3-Agonists [MoA]",
        "Cytochrome P450 2D6 Inhibitors [MoA]",
        "Cytochrome P450 3A Inhibitors [MoA]",
        "P-Glycoprotein Inhibitors [MoA]",
        "beta3-Adrenergic Agonist [EPC]"
      ]
    }
  ]
}